Document is current
Any future updates will be listed below
-
Authors
Xu, Yan
Xiang, Zheng
Alnaggar, Mohammed
Kouakanou, Léonce
Li, Jiawei
He, Junyi
Yang, Jiashuang
Hu, Yi
Chen, Yan
Lin, Li
Hao, Jianlei https://orcid.org/0000-0003-4600-3082
Li, Jingxia
Chen, Jibing
Li, Man
Wu, Qingling
Peters, Christian https://orcid.org/0000-0002-7669-3806
Zhou, Qinghua
Li, Jianshuang
Liang, Yingqing
Wang, Xiaohua
Han, Baohui
Ma, Meili
Kabelitz, Dieter https://orcid.org/0000-0002-4160-7103
Xu, Kecheng
Tu, Wenwei
Wu, Yangzhe
Yin, Zhinan
- License Information
-
More Information
Article History
Received: 15 April 2020
Accepted: 14 July 2020
First Online: 16 September 2020
Competing interests
: A PCT patent (PCT/CN2019/075491) for the new formula for γδ T-cell expansion was filed. D.K. is a member of the Scientific Advisory Boards of Incysus, Imcheck, and Lava Therapeutics.
: All authors who participated in this research agreed to publish this work.
: The study protocol received ethical approval from the Regional Ethics Committee of Guangzhou Fuda Cancer Hospital, China. Written informed consent was obtained from the participants in accordance with the Declaration of Helsinki and ClinicalTrials.gov (NCT03183232, NCT03183219, NCT03183206, and NCT03180437). All animal studies were approved and performed in compliance with the guidelines for the use of experimental animals by the Committee on the Use of Live Animals in Teaching and Research, University of Hong Kong.
